Anna Henriksson1, Cecilia Arving2, Birgitta Johansson3, Helena Igelström2, Karin Nordin4. 1. Department of Public Health and Caring Sciences, Uppsala University, Box 564, 751 22 Uppsala, Sweden. Electronic address: anna.henriksson@pubcare.uu.se. 2. Department of Public Health and Caring Sciences, Uppsala University, Box 564, 751 22 Uppsala, Sweden. 3. Department of Public Health and Caring Sciences, Uppsala University, Box 564, 751 22 Uppsala, Sweden; Department of Immunology, Genetics and Pathology, Uppsala University, Akademiska sjukhuset, Ing 78, 5 tr, 751 85 Uppsala, Sweden. 4. Department of Public Health and Caring Sciences, Uppsala University, Box 564, 751 22 Uppsala, Sweden; Department of Public Health, Sport and Nutrition, University of Agder, Postboks 422, 4604 Kristiansand, Norway.
Abstract
OBJECTIVE: The aim was to describe cancer patients' perceived barriers and facilitators of physical activity during adjuvant cancer treatment. METHODS: Semi-structured focus group interviews were conducted with patients with breast cancer (n=9) and colorectal cancer (n=1) and prostate cancer (n=8) undergoing adjuvant cancer treatment. To capture perceived barriers and facilitators before starting treatment, individual interviews with women with breast cancer (n=5) were also conducted. 23 patients in total, were interviewed, and the transcribed interviews were analysed with qualitative content analysis. RESULTS: Three categories emerged: "Physical and emotional barriers"-addresses experiences of side-effects, co-morbid conditions and emotional barriers, preventing physical activity (PA). "Perspective and attitudes"-how self-efficacy, self-image, preference, concerns, expectations, experience and new perspective regarding one's health influencing PA. "Support and practicalities"-addresses needs of support and information and how practicalities could be a barrier to PA. CONCLUSIONS: Several barriers were side effects of oncological treatment, which can be alleviated by PA. Another barrier was concerns regarding safety of PA during treatment. Communicating benefits and safety of PA to cancer patients early as possible after diagnosis might be beneficial. PRACTICE IMPLICATIONS: Information about PA from health care staff should be given early after diagnosis and as a part of standard care.
OBJECTIVE: The aim was to describe cancerpatients' perceived barriers and facilitators of physical activity during adjuvant cancer treatment. METHODS: Semi-structured focus group interviews were conducted with patients with breast cancer (n=9) and colorectal cancer (n=1) and prostate cancer (n=8) undergoing adjuvant cancer treatment. To capture perceived barriers and facilitators before starting treatment, individual interviews with women with breast cancer (n=5) were also conducted. 23 patients in total, were interviewed, and the transcribed interviews were analysed with qualitative content analysis. RESULTS: Three categories emerged: "Physical and emotional barriers"-addresses experiences of side-effects, co-morbid conditions and emotional barriers, preventing physical activity (PA). "Perspective and attitudes"-how self-efficacy, self-image, preference, concerns, expectations, experience and new perspective regarding one's health influencing PA. "Support and practicalities"-addresses needs of support and information and how practicalities could be a barrier to PA. CONCLUSIONS: Several barriers were side effects of oncological treatment, which can be alleviated by PA. Another barrier was concerns regarding safety of PA during treatment. Communicating benefits and safety of PA to cancerpatients early as possible after diagnosis might be beneficial. PRACTICE IMPLICATIONS: Information about PA from health care staff should be given early after diagnosis and as a part of standard care.
Authors: Vanessa J Thomas; Catherine Seet-Lee; Michael Marthick; Birinder S Cheema; Michael Boyer; Kate M Edwards Journal: Support Care Cancer Date: 2019-05-21 Impact factor: 3.603
Authors: Amy M Dennett; Casey L Peiris; Nicholas F Taylor; Melissa S Reed; Nora Shields Journal: Support Care Cancer Date: 2018-08-22 Impact factor: 3.603
Authors: Kathleen M Sturgeon; Carla Fisher; Gina McShea; Susan Kruse Sullivan; Dahlia Sataloff; Kathryn H Schmitz Journal: Support Care Cancer Date: 2017-08-24 Impact factor: 3.603
Authors: Alessia Ferri; Elise M Gane; Michelle D Smith; Elizabeth P Pinkham; Sjaan R Gomersall; Venerina Johnston Journal: Support Care Cancer Date: 2020-08-01 Impact factor: 3.603
Authors: Sally A D Romero; Justin C Brown; Joshua M Bauml; Jennifer L Hay; Q Susan Li; Roger B Cohen; Jun J Mao Journal: J Cancer Surviv Date: 2018-09-04 Impact factor: 4.442
Authors: Amy M Dennett; Bernadette Zappa; Rachel Wong; Stephen B Ting; Kimberley Williams; Casey L Peiris Journal: Support Care Cancer Date: 2021-05-08 Impact factor: 3.603
Authors: H Helbrich; M Braun; C Hanusch; G Mueller; H Falk; R Flondor; N Harbeck; K Hermelink; R Wuerstlein; S Keim; F Neufeld; S Steins-Loeber; K Haertl Journal: Breast Cancer Res Treat Date: 2021-03-31 Impact factor: 4.872
Authors: Siobhan M Phillips; Whitney A Welch; Jason Fanning; Cesar A Santa-Maria; Kara L Gavin; Lisa A Auster-Gussman; Payton Solk; Marilyn Lu; Erin Cullather; Seema A Khan; Swati A Kulkarni; William Gradishar; Juned Siddique Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-09-29 Impact factor: 4.254